Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis

Fig. 2

Networks of direct comparisons. a All-cause mortality. b Clinical cure. c Microbiological eradication. The size of the nodes and the thickness of the lines indicate the sample size and number of trials, respectively. Lines do not connect nodes when there were no head-to-head trials between two treatments. Abbreviations: CAR carbapenem (imipenem or meropenem), COL colistin, FOS fosfomycin, GLY glycopeptide (vancomycin or teicoplanin), HD high-dose, IH inhaled, IV intravenous, RIF rifampin, SUL sulbactam, TIG tigecycline

Back to article page

Critical Care

ISSN: 1364-8535